322 related articles for article (PubMed ID: 12163562)
1. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly.
Jones RG; Elford AR; Parsons MJ; Wu L; Krawczyk CM; Yeh WC; Hakem R; Rottapel R; Woodgett JR; Ohashi PS
J Exp Med; 2002 Aug; 196(3):335-48. PubMed ID: 12163562
[TBL] [Abstract][Full Text] [Related]
2. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
3. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
Kandasamy K; Srivastava RK
Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743
[TBL] [Abstract][Full Text] [Related]
4. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP).
Suhara T; Mano T; Oliveira BE; Walsh K
Circ Res; 2001 Jul; 89(1):13-9. PubMed ID: 11440972
[TBL] [Abstract][Full Text] [Related]
6. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells.
Van de Sande T; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
Cancer Res; 2002 Feb; 62(3):642-6. PubMed ID: 11830512
[TBL] [Abstract][Full Text] [Related]
7. Impaired Fas response and autoimmunity in Pten+/- mice.
Di Cristofano A; Kotsi P; Peng YF; Cordon-Cardo C; Elkon KB; Pandolfi PP
Science; 1999 Sep; 285(5436):2122-5. PubMed ID: 10497129
[TBL] [Abstract][Full Text] [Related]
8. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation.
Hatano E; Brenner DA
Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1357-68. PubMed ID: 11705740
[TBL] [Abstract][Full Text] [Related]
9. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor promotes cell survival from fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression.
Suzuki A; Hayashida M; Kawano H; Sugimoto K; Nakano T; Shiraki K
Hepatology; 2000 Oct; 32(4 Pt 1):796-802. PubMed ID: 11003625
[TBL] [Abstract][Full Text] [Related]
11. Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes.
Uriarte SM; Joshi-Barve S; Song Z; Sahoo R; Gobejishvili L; Jala VR; Haribabu B; McClain C; Barve S
Cell Death Differ; 2005 Mar; 12(3):233-42. PubMed ID: 15665818
[TBL] [Abstract][Full Text] [Related]
12. The phosphatidylinositol phosphatase PTEN is under control of costimulation and regulates proliferation in human T cells.
Schmidt-Weber CB; Wohlfahrt JG; Akdis CA; Blaser K
Eur J Immunol; 2002 Apr; 32(4):1196-204. PubMed ID: 11932928
[TBL] [Abstract][Full Text] [Related]
13. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
[TBL] [Abstract][Full Text] [Related]
14. Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B.
Parry RV; Reif K; Smith G; Sansom DM; Hemmings BA; Ward SG
Eur J Immunol; 1997 Oct; 27(10):2495-501. PubMed ID: 9368602
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells.
Kirchhoff S; Müller WW; Li-Weber M; Krammer PH
Eur J Immunol; 2000 Oct; 30(10):2765-74. PubMed ID: 11069056
[TBL] [Abstract][Full Text] [Related]
16. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways.
Weng L; Brown J; Eng C
Hum Mol Genet; 2001 Feb; 10(3):237-42. PubMed ID: 11159942
[TBL] [Abstract][Full Text] [Related]
17. Regulation of sensitivity to TRAIL by the PTEN tumor suppressor.
Whang YE; Yuan XJ; Liu Y; Majumder S; Lewis TD
Vitam Horm; 2004; 67():409-26. PubMed ID: 15110188
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi trans-sialidase: a potent and specific survival factor for human Schwann cells by means of phosphatidylinositol 3-kinase/Akt signaling.
Chuenkova MV; Furnari FB; Cavenee WK; Pereira MA
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9936-41. PubMed ID: 11481434
[TBL] [Abstract][Full Text] [Related]
19. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling.
Paez J; Sellers WR
Cancer Treat Res; 2003; 115():145-67. PubMed ID: 12613196
[No Abstract] [Full Text] [Related]
20. PI3K/Akt and apoptosis: size matters.
Franke TF; Hornik CP; Segev L; Shostak GA; Sugimoto C
Oncogene; 2003 Dec; 22(56):8983-98. PubMed ID: 14663477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
